Amdocs (DOX) Research & Development (2009 - 2026)

Amdocs has disclosed Research & Development across 18 years of filings, most recently posting $87.0 million for Q1 2026.

• In Q1 2026, Research & Development rose 6.36% year-over-year to $87.0 million; the TTM figure through Mar 2026 stood at $343.7 million (down 0.83% YoY), while the FY2025 annual figure was $340.8 million, down 5.53% from the prior year.
• Research & Development grew to $87.0 million in Q1 2026, from $82.0 million in the prior quarter.
• Over the last five years, Research & Development for DOX reached as high as $97.7 million in Q3 2023 and fell as low as $81.8 million in Q1 2025.
• The 5-year median for Research & Development is $89.3 million (2023), against an average of $89.3 million.
• Annual changes were most pronounced in 2022 — Research & Development rose 18.31% — and 2025, when it dropped 10.27%.
• A 5-year view of Research & Development shows it stood at $95.7 million in 2022, then dropped by 6.81% to $89.2 million in 2023, then slipped by 5.46% to $84.3 million in 2024, then fell by 2.79% to $82.0 million in 2025, then rose by 6.13% to $87.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $87.0 million, $82.0 million, and $87.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.